We provide 1 form of Crisaborole
Crisaborole
906673-24-3
|
251.075
|
2.629
Crisaborole has broad-spectrum anti-inflammatory activity by mainly targeting phosphodiesterase 4 (PDE4) enzyme that is a key regulator of inflammatory cytokine production. It is intended for the topical treatment of mild to moderate atopic dermatitis in patients 2 years of age and older.
5-(4-cyanophenoxy)-1,3-dihydro-1-hydroxy-[2,1]-benzoxaborole | AN2728 | crisaborole
Crisaborole has broad-spectrum anti-inflammatory activity by mainly targeting phosphodiesterase 4 (PDE4) enzyme that is a key regulator of inflammatory cytokine production. It is intended for the topical treatment of mild to moderate atopic dermatitis in patients 2 years of age and older.
5-(4-cyanophenoxy)-1,3-dihydro-1-hydroxy-[2,1]-benzoxaborole | AN2728 | crisaborole
$41/5 mg
(EBC)
1
We provide 0 compound for Crisaborole